Evidence map›Paper›PMID 29055989›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2017

[The Value of SMI in the Evaluation of interventional therapy of liver cancer].

S Q Liu, Y B Ma, Z H Han, X Xie, C Y Wang, Y Tao, H Chen, Y P Liu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

S Q LiuDepartment of Medical Ultrasonic, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, China.
Y B MaDepartment of Medical Ultrasonic, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, China.
Z H HanDepartment of Interventional Radiology, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, China.
X XieDepartment of Medical Ultrasonic, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, China.
C Y WangDepartment of Interventional Radiology, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, China.
Y TaoDepartment of Statastics, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, China.
H ChenDepartment of Medical Ultrasonic, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, China.
Y P LiuDepartment of Medical Ultrasonic, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, China.
Changzhou Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Liver NeoplasmsChemoembolization, TherapeuticHumansDoppler, colorLiver neoplasmsSuper microvascular imagingTranscatheter arterial chemoembolization

Identifiers

PMID29055989
PMCPMC12814658
OpenAlexW2801053949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.